# Amneal Pharmaceuticals, Inc.: Form 8-K, filed Feb 4, 2020

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K
- Filed: 2020-02-04
- Accepted by EDGAR: Feb 3, 2020, 19:51 ET
- Period: 2020-01-31
- Accession: 0001193125-20-023178
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000119312520023178/d855102d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000119312520023178/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000119312520023178/d855102d8k.htm

Filed Feb 4, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-023178. Last ingested by Listed: Nov 10, 2026, 02:45 ET. No prices; not investment advice.
